CYP19 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP19 monoclonal antibodies for investigating aromatase in various biological processes. CYP19 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP19, also known as aromatase, is a critical enzyme responsible for the conversion of androgens to estrogens, playing a vital role in steroidogenesis and reproductive health. Dysregulation of CYP19 has been implicated in various conditions, including hormone-dependent cancers and metabolic disorders. Understanding CYP19 function is essential for developing targeted therapies and advancing knowledge of endocrine signaling. CYP19 monoclonal antibodies enable precise detection and quantification of aromatase expression in diverse experimental settings. Researchers can utilize CYP19 monoclonal antibodies to explore molecular mechanisms underlying estrogen biosynthesis and regulation. Advanced research techniques incorporating CYP19 monoclonal antibodies help uncover new insights into hormone-related pathways and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by providing reliable tools for investigating crucial enzymes like CYP19 in health and disease research.